These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19749689)

  • 1. Facial aesthetics: is botulinum toxin treatment effective and safe? A systematic review of randomised controlled trials.
    Gadhia K; Walmsley AD
    Br Dent J; 2009 Sep; 207(5):E9; discussion 216-7. PubMed ID: 19749689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A therapy for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003633. PubMed ID: 15674910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
    Duarte GS; Castelão M; Rodrigues FB; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD004314. PubMed ID: 27782297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A therapy for hemifacial spasm.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD004899. PubMed ID: 15674968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type A therapy for blepharospasm.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004900. PubMed ID: 15674969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Events of Botulinum Toxin Type A in Facial Rejuvenation: A Systematic Review and Meta-Analysis.
    Jia Z; Lu H; Yang X; Jin X; Wu R; Zhao J; Chen L; Qi Z
    Aesthetic Plast Surg; 2016 Oct; 40(5):769-77. PubMed ID: 27495260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004; (3):CD003469. PubMed ID: 15266487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A as an adjunct to treatment in the management of the upper limb in children with spastic cerebral palsy.
    Wasiak J; Hoare B; Wallen M
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003469. PubMed ID: 15495055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin type A versus botulinum toxin type B for cervical dystonia.
    Costa J; Borges A; Espírito-Santo C; Ferreira J; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004314. PubMed ID: 15674940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind Trials.
    Guo Y; Lu Y; Liu T; Zhou Y; Yang P; Zhu J; Chen L; Yang Q
    Plast Reconstr Surg; 2015 Sep; 136(3):310e-318e. PubMed ID: 26313835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A in the treatment of lower limb spasticity in cerebral palsy.
    Ade-Hall RA; Moore AP
    Cochrane Database Syst Rev; 2000; (2):CD001408. PubMed ID: 10796784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A therapy for hemifacial spasm.
    Duarte GS; Rodrigues FB; Castelão M; Marques RE; Ferreira J; Sampaio C; Moore AP; Costa J
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD004899. PubMed ID: 33211908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of safety data from five phase III clinical trials on the use of botulinum neurotoxin type A-ABO for the treatment of glabellar lines.
    Rubin M; Dover J; Maas C; Nestor M
    Aesthet Surg J; 2009 Nov; 29(6 Suppl):S50-6. PubMed ID: 19945005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A versus anticholinergics for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; 2005(1):CD004312. PubMed ID: 15674939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study.
    Ziade M; Domergue S; Batifol D; Jreige R; Sebbane M; Goudot P; Yachouh J
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):209-14. PubMed ID: 23102873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on botulinum toxin for facial aesthetics.
    Cather JC; Cather JC; Menter A
    Dermatol Clin; 2002 Oct; 20(4):749-61. PubMed ID: 12380062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA; Fedorowicz Z; Al Bareeq J; Al Bareeq R; Nasser M
    Cochrane Database Syst Rev; 2009 Jan; (1):CD007510. PubMed ID: 19160335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.
    Magid M; Reichenberg JS; Poth PE; Robertson HT; LaViolette AK; Kruger TH; Wollmer MA
    J Clin Psychiatry; 2014 Aug; 75(8):837-44. PubMed ID: 24910934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multipoint and multilevel injection technique of botulinum toxin A in facial aesthetics.
    Iozzo I; Tengattini V; Antonucci VA
    J Cosmet Dermatol; 2014 Jun; 13(2):135-42. PubMed ID: 24910277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.